Published on
July 29, 2026
- 13:00 GMT
Elix and University of Vienna Enter Joint Research Agreement for AI Drug Discovery
TOKYO, JAPAN, July 29, 2026 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) and University of Vienna, Austria (represented by the Dean of the Faculty of Life Sciences, Prof. Mag. Dr. Karl-Heinz Wagner; …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
